Hint mode is switched on Switch off
For swift navigation between sections

Kinnate Biopharma
LEI 549300YVIWV7HJ5WHI66

PDF download

Choose all Reset all
Download Cancel
Organization name
Kinnate Biopharma Inc
Country name
USA
Country of registration
USA
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
-

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

Kinnate Biopharma Inc operates as a biopharmaceutical company. The Company focuses on the discovery and development of small molecule kinase inhibitors for difficult-to-treat, genomically defined cancers.

Awards

News

03/04/2024 Kinnate Biopharma: Of This Current Report On Form, Material Modification To Rights Of Security Holders, Changes In Control Of Registrant, Departures Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Departures Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Other Events, Financial Statements And Exhibits
27/02/2024 Kinnate Biopharma: Entry Into A Material Definitive Agreement, Completion Of Acquisition Or Disposition Of Assets, Regulation Fd Disclosure, Financial Statements And Exhibits
16/02/2024 Kinnate Biopharma: Entry Into A Material Definitive Agreement, Regulation Fd Disclosure, Financial Statements And Exhibits
09/01/2024 Kinnate Biopharma: Regulation Fd Disclosure, Financial Statements And Exhibits
16/11/2023 Kinnate Biopharma: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers
All organization news

Documentation

IFRS/US GAAP reports

2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
Show all Hide
Authorization required
You need to request access

Stocks

Public debt by currencies

Show more Hide

Codes

  • LEI
    549300YVIWV7HJ5WHI66
  • SIC
    2834 PHARMACEUTICAL PREPARATIONS
  • CIK
    0001797768
  • EIN
    82-4566526
Registration is required to get access.